MAXCYTE, INC.·4

Mar 18, 8:51 PM ET

Soleymannezhad Ali 4

4 · MAXCYTE, INC. · Filed Mar 18, 2025

Insider Transaction Report

Form 4
Period: 2025-03-14
Soleymannezhad Ali
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-03-14+138,500138,500 total
    Exercise: $3.29Exp: 2035-03-13Common Stock (138,500 underlying)
  • Award

    Common Stock

    2025-03-14+34,62560,650 total
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 14, 2026, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
  • [F2]Twenty-five percent (25%) of the shares underlying this option shall vest on March 14, 2026, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary